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Objective: The clinical results after stenting in the coronary and peripheral circulations are vastly different. Possible
explanations for this discrepancy include generally longer and more complex lesions in the periphery, variable vascular
responses to injury according to anatomic location, disparate blood flow rates, and impedance in coronary vs skeletal
smooth muscle beds, or phenotypic differences in neointimal hyperplasia and remodeling. This study examined the
long-term results (6 months) after implantation of phosphorylcholine-coated balloon-expandable stents in a porcine
model of experimental in-stent coronary and peripheral arterial restenosis.
Methods: Forty-eight stainless steel-tantalum-stainless steel composite balloon-expandable stents coated with phospho-
rylcholine (TriMaxx stent, Abbott Laboratories, Abbott Park, Ill) were implanted in the coronary (3.0  15 mm) or
larger femoral arteries (4.0  38 mm) of Yorkshire crossbred swine to achieve a 1.1:1 stent-to-artery ratio. After 28, 90,
or 180 days, the arteries were excised, perfusion-fixed at 100 mm Hg, sectioned, and stained with hematoxylin and eosin
for morphometric evaluation.
Results: One animal did not survive to euthanasia; all arteries in surviving animals were patent. No significant differences
were found in mean injury or inflammation scores among the groups or time points. The larger femoral arteries generated
more neointimal area over time than the coronary arteries. The neointimal area in coronary arteries was 2.76  0.71,
1.75 0.42, and 1.83 0.19 mm2 at 28, 90, and 180 days, respectively, and 5.20 0.97, 3.11 0.53, and 5.10 0.80
mm2 in the femoral arteries (P < .05 coronary vs femoral at 180 days). This led to statistically significantly increased
percent area stenosis at 180 days (coronary 27%  4% vs femoral 45%  5%; P < .05).
Conclusions:The vascular response to balloon-expandable stenting in the coronary and peripheral circulations is different.
After 6 months, neointimal hyperplasia and stent-induced stenosis were increased in peripheral porcine arteries compared
with coronary arteries. ( J Vasc Surg 2007;45:821-7.)
Clinical Relevance: Atherosclerotic vascular disease and its sequelae remain the single greatest killers in the world.
Significant advances have been made in the development of endovascular techniques for both coronary and peripheral
interventions. Although endovascular intervention is highly effective in the coronary and iliac arterial system, it has been
shown to be less effective in the infrainguinal circulation. In this study, we tested the hypothesis that the post-stenting
neointimal and remodeling responses of normal porcine peripheral arteries was different than that of the coronary arteries
receiving identical stents and that inherently less favorable remodeling in the periphery might help to explain the
seemingly disparate clinical results of endovascular intervention.Atherosclerotic vascular disease and its sequelae remain
the single greatest killers in the world.1 The clinical events
generated by atherosclerosis, including myocardial infarc-
tion, stroke, renal failure, and amputation, result in 17
million deaths per year, about 46,000 per day. More than 6
million surgical or interventional procedures designed to
restore blood flow are performed annually, comprising the
largest single category of major operations.
Once amenable only to open surgical revascularization
with bypass grafting, the possibility of endovascular therapy
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doi:10.1016/j.jvs.2006.12.012for atherosclerotic vascular disease was first advanced in
1964 when Dotter and Judkins2 described percutaneous
transluminal coaxial angioplasty. The procedure remained
largely experimental until Andreas Grüntzig et al3,4 intro-
duced percutaneous transluminal coronary balloon angio-
plasty in the late 1970s. The rapid evolution of advanced
endovascular techniques in the coronary arteries, including
intravascular stenting5 and implantation of drug-eluting
stents,6,7 has revolutionized the treatment of coronary
atherosclerosis such that it is estimated that 2 million
percutaneous coronary interventions (PCI) are performed
annually. With the introduction of drug-eluting stents in
2001, PCI has become safe and effective, with procedural
success rates generally 95%, and event-free survival of
roughly 90% at 1 year.8-10
The development of endovascular intervention in the
peripheral circulation has been no less rapid. Percutaneous
821
JOURNAL OF VASCULAR SURGERY
April 2007822 Dubé et altransluminal balloon angioplasty and balloon-expandable
stenting were introduced in the 1980s,11,12 and self-
expanding stents originally developed for use in the biliary
tree were adapted for the peripheral vasculature in the
1990s.13 Endovascular intervention is highly effective in
the iliac arterial system, with technical success rates 95%,
and 5-year patency of 75% to 90% depending on lesion
length and complexity.14
The techniques are generally less effective in the infrain-
guinal circulation, however. Although short-term primary
patency 80% can be achieved after treatment of relatively
simple TransAtlantic Inter Society Consensus (TASC) cat-
egory A (3 cm) or B femoropopliteal lesions (3 to 10 cm),
long-term patency after endovascular treatment of more
complex lesions in the femoropopliteal and infrapopliteal
segments is generally 50%.14-21
The potential explanations for the decreased efficacy of
peripheral endovascular intervention are many, including
longer and more complex lesions in the periphery, in-
creased plaque burden, asymmetric limb movement, de-
creased mean flow and shear stress, relatively prolonged
periods of stasis within the cardiac cycle, phenotypic differ-
ences in neointimal hyperplasia and remodeling, increased
thrombogenic potential, the lack of available drug-eluting
stents, or the recently reported tendency of peripheral
stents toward fracture.22,23
The purpose of this experiment was to test the hypoth-
esis that the post-stenting neointimal and remodeling re-
sponses of normal porcine peripheral arteries is different
than that of the coronary arteries receiving identical stents
(matched for arterial size), and that inherently less favorable
remodeling in the periphery might help to explain the
seemingly disparate clinical results of endovascular inter-
vention.
METHODS
Animal operations. The domestic Yorkshire cross-
bred swine (Pork Power Farms, Turlock, Calif) was chosen
as the experimental species for this study. The body weights
of the animals were about 30 to 50 kg at implantation.
Animals were fed standard, noncertified pig chow. All
studies were conducted in a test facility accredited by the
Association for the Assessment and Accreditation of Labo-
ratory Animal Care and registered with the United States
Department of Agriculture to conduct research in labora-
tory animals. All the conditions of testing conformed to the
Animal Welfare Act (CFR 9) and its amendments. The
protocol was reviewed and approved by the Animal Care
and Use Committee at the test facility for compliance with
regulations before study initiation.
At least 1 day before the stent implant procedure, 325mg
aspirin and 75 mg clopidogrel (Plavix, Sanofi-Aventis,
Bridgewater, NJ) were administered to each animal by
mouth as a daily single dose, and continued at the same
dose daily until study termination.
Intravascular stent implantation. After induction of
anesthesia, an incision was made in the neck to expose the
carotid artery. A 7F arterial sheath was introduced andadvanced into the vessel and, under fluoroscopy, a guiding
catheter and 0.035-inch guidewire were inserted through
the sheath and used to gain access to arteries intended for
treatment. The tip of the guiding catheter was used as a
reference to obtain angiographic images of the vessels for
selection of sites judged to be appropriate for stent implant
at an approximate stent-to-artery ratio of 1.1 to 1.0. Hep-
arin (150 to 200 IU/kg) was administered intravenously to
achieve a target activated clotting time (ACT) of 250
seconds. Additional heparin was occasionally necessary to
maintain this anticoagulation target.
For each target site, a 0.014-inch guidewire was ad-
vanced through the guiding catheter within the target
vessel just beyond the target implant site. Stent delivery
systems were prepared for inflation by twice drawing neg-
ative pressure with a 10 mL or larger syringe and then
advancing via the guide and guidewire to the target implan-
tation site.
The TriMaxx stents (Abbott Laboratories, Abbott
Park, Ill) used in this study are cut from three-layer lami-
nated tubing composed of an inner layer of 316L stainless
steel, a middle layer of tantalum, and an outer layer of 316L
stainless steel. In its cut and polished state, the inner and
outer surfaces of the stent are pure stainless steel, with a
band of tantalum exposed along the sidewalls of the struts.
The strut thickness is 0.0029-inch for a balance of perfor-
mance and radiopacity. The stents are coated with phos-
phorylcholine, a methacrylate polymer formulated to pro-
vide adhesion to stainless steel, cross-linking capability, and
biocompatibility to the coated surface.
In the coronary arteries (left anterior descending, left
circumflex, or right coronary artery), 3.0 15 mm stents
were implanted and 4.0 38 mm stents were implanted in
the larger femoral arteries. Only one stent was placed in
each artery. After stent deployment, the balloon was de-
flated and the stent delivery system withdrawn. At the
conclusion of the procedure, the guidewire and introducer
sheath were removed, the artery ligated, and the wound
closed in layers.
It should be noted that these animals also received
other bare metal test stents in other arteries during this
operation because this study was originally designed within
a larger industrial development program. Experimental an-
imals received up to three stents in the coronary arteries and
up to one stent in each of the left and right femoral arteries,
for a maximum of five stents per animal. This report de-
scribes only the subset of the identical stents implanted in
the coronary and peripheral arteries to address the specific
hypothesis in question.
Tissue collection, preparation, and evaluation. At
the time of scheduled euthanasia (28  2, 90  3, and
180  5 days), the hearts were collected from all animals,
flushed with 0.9% saline solution, and perfusion fixed with
10% neutral-buffered formalin solution. The treated pe-
ripheral arteries were removed, with at least 1 cm of prox-
imal and distal host vessel attached, flushed with saline or
formalin, or both, and placed in formalin.
le.
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individually infiltrated and embedded in hard plastic
(methyl methacrylate). The embedded explants were step-
sectioned at three levels using amicrotome for the coronary
stents and a band saw and fine grinding for the femoral
stents. Three in-stent sections were analyzed: the proximal
stent (about 2 mm into the proximal stent), mid-stent
(about the middle of the stent) and distal stent (about
2 mm from the distal end of the stent). The sections were
mounted on slides and stained. All sections were stained
with hematoxylin and eosin, and elastin stains.
Semiquantitative histopathologic evaluation included
tabulation of vessel injury score,24 inflammation score,25
and endothelialization score (Table I). Quantitative mor-
phometric measurements using digital planimetry (Bio-
quant TCW98 Image Analysis System, R&M Biometrics,
Nashville, Tenn) included cross-sectional areas of the ex-
ternal elastic lamina (EEL), internal elastic lamina (IEL),
and lumen. The average distance from the abluminal side of
each strut to the lumen was considered the neointimal
thickness. Derived measurements included neointimal area
(IEL area – lumen area) and percent area stenosis ([1 –
(Lumen area/IEL area)] 100). Media area was obtained
by subtraction of the internal elastic lamina area from the
external elastic lamina area.
Statistical analysis. Measurements for each stented
vessel (proximal, mid, and distal stent) were averaged to
produce a mean value per stent. One-way analyses of vari-
Table I. Grading scores for injury, inflammation, and end
0 1
Injury Endothelium
denuded
IEL lacerated Media
Inflammation No inflammatory
cells
Mild inflammatory
response but not
circumferential
Mode
agg
non
Endothelialization Absent
endothelium
Endothelial-like cells
present, 25% of
the lumen
circumference
Endo
pre
circ
IEL, Internal elastic lamina; EEL, external elastic lamina; N/A, not applicab
Table II. Quantitative angiography results*
Days Stent N Preim
28 3.0 8 2.88 
4.0 8 3.94 
90 3.0 8 2.98 
4.0 7 3.84 
180 3.0 8 2.88 
4.0 7 3.91 
*Results are presented as means  standard deviation.ance were used to compare the treatment groups, and theBonferroni multiple comparison test was used to detect
differences between the groups. Tests of significance
were two-tailed, and significance was established by a
value of P  .05. Unless otherwise noted, data are
reported as mean  standard error of the mean.
RESULTS
One animal did not survive to the time of scheduled
euthanasia; all arteries in the surviving animals were patent.
Average weights at implant and euthanasia were 33.5 and
41.8 kg for the 28-day group, 33.0 and 69.8 kg for the
90-day group, and 33.8 and 120.8 kg for the 180-day
group. Quantitative angiography was used to determine
vessel diameters before implant and after implant (Table II).
Stent-to-artery ratio was calculated by dividing the postim-
plant vessel diameter by the preimplant vessel diameter.
Across the different time points, there were no statistically
significant (P  .05) differences in preimplant or postim-
plant vessel diameters or mean stent-to-artery ratios among
the 3.0-mm or 4.0-mm devices. These data indicate that at
each time point, the devices were implanted into vessels of
similar size and with similar stent-to-artery ratios.
Representative sections from the two groups and three
time points are shown in Fig 1. At 28 days, remodeling of
the vessel wall was minimal in most sections from both
coronary and peripheral stent groups and consisted of
medial smooth muscle cell hyperplasia in the interstrut
regions. At 90 days, neointimal growth generally consisted
lialization
Score
2 3 4
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to-dense cellular
e but
mferentially
Circumferential
dense cell
infiltration of the
struts
N/A
l-like cells
25%-50% of the
rence
Endothelial-like cells
present, 50%-75%
of the
circumference
Complete circumferential
endothelialization
Diameter (mm)
Stent-to-artery ratiot Postimplant
3.16  0.26 1.10  0.11
4.27  0.40 1.08  0.08
3.20  0.27 1.08  0.08
4.02  0.40 1.04  0.06
2.99  0.26 1.04  0.04
4.27  0.33 1.09  0.07othe
lace
rate-
regat
circu
thelia
sent,
umfeplan
0.25
0.16
0.12
0.24
0.17
0.21of mature fibromuscular tissue adjacent to the vessel lumen.
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coronary (top panel) and peripheral (bottom panel) por-
cine arteries after (A) 28 days, (B) 90 days, and (C) 180
days. (Hematoxylin and eosin stain; original magnifica-
tion 10-13.)
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which tended to be asymmetric owing to the sometimes
unequal-appearing expansion of struts. At 180 days, vessel
wall remodeling was characterized by medial hypocellular-
ity, neovascularization, fibrosis, or smooth muscle cell re-
placement, or both, or hyperplasia.
Neointimal growth consisted of mature fibromuscular
tissue adjacent to the vessel lumen. Similar to the 90-day
results, neointima tended to be asymmetric owing to the
occasional unequal expansion of some stents in peripheral
arteries. Stent deformation, when present, likely occurred
after implantation, potentially as a result of compression
and animal movement during the follow-up period.
Histomorphometric results are presented numerically
in Table III. Average injury scores were 1, reflecting
minimal damage to the structural integrity of the vessel
wall, and no statistically significant differences were noted
between groups or among time points. Peristrut inflamma-
tion and neointimal fibrinoid deposits or hemorrhage, or
both, were minimal to mild, with no significant differences
in inflammation scores across the study. Neointimal endo-
thelialization was essentially complete in most of the sec-
tions from all coronary stents. Endothelialization appeared
less complete over some peripheral stents with inadequately
apposed struts, although endothelialization scores were3.8
in all groups.
Morphometric evaluation revealed larger luminal and
medial areas in stented peripheral arteries compared with
coronary arteries at each time point, reflecting the obvi-
ously larger-sized peripheral arteries. The amount of neo-
intimal hyperplasia generated by peripheral stenting was
also larger at each time point (Table III). Its increase was
disproportionate, however, resulting in a greater degree of
area stenosis in the peripheral arteries compared with the
coronary arteries at 180 days (Table III, Fig 2). Similarly,
the lumen-to-artery ratio in the peripheral arteries was
Table III. Histomorphometric results after balloon-expan
peripheral arteries*
Coronary (3.0-mm  15-mm
Time of harvest (days) 28 90
N 8 8
Stent size (mm) 3.0  15 3.0  15
Score
Injury 0.54  0.34 0.70  0.4
Inflammation 1.13  0.42 1.30  0.27
Endothelialization 4.0  0 3.9  0.08
Neointimal area (mm2) 2.76  0.71 1.75  0.42
Medial area (mm2) 1.20  0.14 1.05  0.07
Lumen area (mm2) 3.66  0.61 5.10  0.51
Area stenosis (%) 42  9 26  6
Lumen/artery ratio 0.50  0.08 0.64  0.06
*Data are presented as mean  standard error of the mean.
†P  .005 compared with coronary arteries at corresponding time point.
‡P  .0005 compared with coronary arteries at corresponding time point.
§P  .05 compared with coronary arteries at corresponding time point.lower at each time point of the study (Table III, Fig 3).DISCUSSION
Endovascular techniques have revolutionized the treat-
ment of fixed end-stage atherosclerotic lesions in the arte-
rial tree. Once amendable only to open surgical revascular-
ization, a wide range of critical stenoses and even total
occlusions can now be approached percutaneously. Endo-
vascular interventions within coronary arteries are particu-
larly effective and have become the preferred method of
treatment formost patients with occlusive syndromes of the
coronary circulation.26
Endovascular intervention in the peripheral circulation
has proven more problematic. Although generally effective
in the relatively large inflow arteries of the extracranial
cerebrovascular and iliac circulations, endovascular manip-
ulation of the infrainguinal arteries is technically more
challenging, and the clinical results generally inferior. For
example, the Bypass Versus Angioplasty in Severe Ischemia
of the Leg (BASIL) trial, designed to compare the out-
comes of infrainguinal bypass surgery and balloon angio-
plasty in a cohort of 452 patients with limb-threatening
e stent implantation in the coronary and
t) Peripheral (40-mm  28-mm stent)
180 28 90 180
8 8 7 7
.0  15 4.0  28 4.0  28 4.0  28
7  0.12 0.83  0.16 0.70  0.24 0.02  0.02
1  0.12 1.33  0.15 0.80  0.19 0.00  0.00
0  0 4.0  0 4.0  0 4.0  0
3  0.19 5.20  0.97 3.11  0.53 5.10  0.80†
0  0.14 2.77  0.30† 2.02  0.16† 3.45  0.23‡
3  0.42 8.80  0.88† 6.10  0.63 6.35  0.87†
7  4 56  5 36  6 45  5§
2  0.03 0.53  0.04 0.55  0.04 0.42  0.05†
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Fig 2. Percent area stenosis in stented coronary and peripheral
porcine arteries. Data are presented as mean  standard error of
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Unfortunately, patients treated with bypass surgery ulti-
mately fared no better, and no significant differences were
noted in 3-year amputation-free survival between the two
treatments (surgery, 57% vs angioplasty, 52%).
The possible explanations for the discouraging results
of infrainguinal endovascular intervention are many. The
infrainguinal circulation is unique in several regards, in-
cluding its very long and diminutive vessels, its high imped-
ance outflow bed, its resultant low mean flow rates and
prolonged fractions of the cardiac cycle with stagnant
flow,27 and its tendency toward exaggerated bending and
twisting with skeletal movement.28 Endovascular interven-
tion in this region must maintain patency despite heavy,
complex plaque burdens, multiple serial stenoses and oc-
clusions, sluggish blood flow, low mean and oscillatory
shear stress, and repetitive axial, radial, and torsional forces.
This latter phenomenon, that of repetitive external biome-
chanical forces as stimuli for neointimal hyperplasia, is
supported by the experimental finding that stents placed in
the more distal femoral arteries of animals generally re-
model poorly compared with the iliac arteries.29,30
It is also possible that the peripheral arterial vascular
bed inherently responds unfavorably to mural injury com-
pared with the coronary arteries, and this hypothesis was
investigated in this study. Balloon-expandable stents con-
structed with identical metal and topographic patterns were
simultaneously implanted into coronary and peripheral ar-
teries of the same animal. Different sized stents were used in
the different vascular beds, such that the stent-to-artery
ratio was held constant which, predictably, also held con-
stant the histologic injury score. With this strategy, it was
possible to examine whether peripheral and coronary arter-
ies subjected to the same injury would respond in a similar
fashion.
The results of this investigation suggest that the periph-
eral arteries may indeedmount amore pronounced vascular
response than their coronary counterparts. Morphometric
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Fig 3. Lumen-to-artery ratio in stented coronary and peripheral
porcine arteries. Data are presented as mean  standard error of
the mean. **P  .005 compared with coronary arteries.evaluation of the stented peripheral arteries revealed in-creased neointimal area in response to stenting compared
with the coronary arteries. This was an expected result, of
course, because the larger peripheral arteries contain more
absolute smooth muscle cell mass available for remodeling.
The net result was a greater area of stenosis in the peripheral
arteries (45%) compared with the coronary arteries (27%)
after 6 months. This implies an intrinsic difference in re-
modeling response.
Also notable is the time course over which this response
progresses. As seen in Fig 2, remodeling in response to
coronary artery stenting appears to stabilize or decrease
over time, a finding noted in other experimental studies as
well as in human arteries.31 In contrast, area stenosis in the
stented peripheral arteries in this study continued to in-
crease throughout the study period, and was maximal at the
final time point of 6 months.
CONCLUSION
The results of this experimental study suggest that the
vascular response to balloon-expandable stenting in the
coronary and peripheral circulations is different. It is theo-
rized that the chronic low mean and oscillatory shear envi-
ronment, as well as the unpredictable bending and torsion
inherent in the periphery, leads to increased area stenosis
and decreased lumen-to-artery ratio in stented remodeled
peripheral arteries.
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